A detailed history of Lido Advisors, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Lido Advisors, LLC holds 20,100 shares of GKOS stock, worth $2.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
20,100
Previous 20,100 -0.0%
Holding current value
$2.4 Million
Previous $1.6 Million 18.66%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$43.88 - $52.48 $4,388 - $5,248
100 Added 0.5%
20,100 $1.01 Million
Q3 2022

Nov 14, 2022

BUY
$46.84 - $58.49 $936,800 - $1.17 Million
20,000 New
20,000 $1.06 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $5.68B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Lido Advisors, LLC Portfolio

Follow Lido Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lido Advisors, LLC with notifications on news.